About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Lupus
›
Top Articles
Lupus
Rheumatology
2.6
(top 6%)
Impact Factor
2.9
(top 6%)
extended IF
109
(top 3%)
H-Index
2.9K
authors
5.6K
papers
128.2K
citations
5.3K
citing journals
32.7K
citing authors
Most Cited Articles of Lupus
Title
Year
Citations
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
2003
585
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
2006
554
Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus
2000
392
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
2011
351
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
2000
349
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients
2007
306
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity
2004
281
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
2006
279
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
2001
275
Mechanisms of action of mycophenolate mofetil
2005
274
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture
1999
260
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
2002
256
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
2008
241
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection
1992
238
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases
2009
237
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
1995
236
Cardiac involvement in systemic lupus erythematosus
2005
230
The innate immune system in SLE: type I interferons and dendritic cells
2008
226
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis
1997
217
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies
1997
215
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus
2001
210
Rationale for interleukin-6 blockade in systemic lupus erythematosus
2004
209
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
2013
205
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
1998
202
A review of health related quality of life in systemic lupus erythematosus
2006
192
previous
2009
2010
2011
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.